191111-27-0

Usage

Uses

Used in Organic Synthesis:
Methyl 1-(Boc-aMino)-4-oxo-cyclohexanecarboxylate is used as a building block in organic synthesis for the preparation of various pharmaceuticals and biologically active molecules. Its Boc protecting group allows for selective removal under mild conditions, facilitating the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Methyl 1-(Boc-aMino)-4-oxo-cyclohexanecarboxylate serves as a key intermediate in the development of new pharmaceuticals. Its versatility and the ability to selectively remove the Boc protecting group make it an essential component in the synthesis of diverse biologically active compounds.
Used in Drug Discovery and Development:
Methyl 1-(Boc-aMino)-4-oxo-cyclohexanecarboxylate has potential applications in drug discovery and development. Its role as a building block in the synthesis of pharmaceuticals and biologically active molecules contributes to the identification and development of new drugs with therapeutic potential.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Methyl 1-(Boc-aMino)-4-oxo-cyclohexanecarboxylate is used as a key intermediate for the synthesis of various drugs. Its unique properties and the ability to selectively remove the Boc protecting group make it an indispensable component in the development of new therapeutic agents.

Upstream product

• 285996-76-1 1-((tert-butoxycarbonyl)amino)-4-oxocyclohexanecarboxylic acid 
• 74-88-4 methyl iodide 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 191110-78-8 syn/anti-1-[N-(t-butoxycarbonyl)amino]-4-hydroxycyclohexane-1-carboxylic acid methyl ester 

Downstream Products

• 917887-43-5 syn-1-[N-(t-butoxycarbonyl)amino]-4-hydroxycyclohexane-1-carboxylic acid methyl ester 
• 1178976-85-6 Methyl trans-1-tert.-butoxycarbonylamino-4-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-cyclohexanecarboxylate 
• 1178976-86-7 methyl cis-1-tert.-butoxycarbonylamino-4-methanesulphonyloxy-cyclohexanecarboxylate 
• 753441-74-6 C₉H₁₇NO₃ 
• 191110-78-8 syn/anti-1-[N-(t-butoxycarbonyl)amino]-4-hydroxycyclohexane-1-carboxylic acid methyl ester 
• 887245-67-2 methyl 1-amino-4-oxocyclohexanecarboxylate 
• 917887-38-8 anti-1-[N-(t-butoxycarbonyl)amino]-4-hydroxycyclohexane-1-carboxylic acid methyl ester 

Relevant academic research and scientific papers

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

Spirocyclic Heterocycles Medicaments Containing Said Compounds, Use Thereof And Method For Their Production

The present invention relates to spirocyclic heterocycles of general formula (I) the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which

Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging

The radiolabeled non-natural amino acid 1-amino-3-cyclobutane-1-carboxylic acid (ACBC) and its analogs are candidate tumor imaging agents useful for positron emission tomography and single photon emission computed tomography due to their selective affinity for tumor cells. The present invention provides methods for stereo-selective synthesis of syn-ACBC analogs. The disclosed synthetic strategy is reliable and efficient and can be used to synthesize a gram quantity of various syn-isomers of the ACBC analogs, particularly, syn-[18F]-1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC) and syn-[123I]-1-amino-3-iodocyclobutane-1-carboxylic (IACBC) acid analogs.